PDF(Pubmed)
Abstract：
BACKGROUND: Workplace cancer screening programs are determined as part of an employee\'s benefits package and health checkups are perceived positively. However, the current status of workplace cancer screening programs in Japan is unavailable. This study aimed to assess the adherence to national guidelines for colorectal, breast, and cervical cancer screenings in the workplace among Japanese enterprises and identify factors associated with excessive or inadequate screenings.
METHODS: A cross-sectional study design was employed. Data were obtained from a survey conducted by the \"Corporate Action to Promote Cancer Control\" between November and December 2022 among registered partner enterprises in Japan. The survey included questions on background characteristics, cancer screening practices, and intervention approaches. The analysis included 432 enterprises that provided complete responses regarding colorectal, breast, and cervical cancer screenings.
RESULTS: The guideline-adherence rates for colorectal, breast, and cervical cancer screenings in the workplace were 12.7%, 3.0%, and 8.8%, respectively. Enterprises had lower adherence to screening guidelines than local governments. Colorectal (70.8%) and breast (67.1%) cancer screenings were predominantly categorized as \"overscreening\" and cervical (60.6%) cancer screening, as \"underscreening.\" Factors such as enterprise scale, health insurance associations, and the number of interventional approaches were significantly associated with increased \"overscreening\" (101-1000: β = 0.13, p = 0.01; ≥ 1000: β = 0.17, p < 0.01; health insurance association: β = 0.23, p < 0.01; and approaches: β = 0.42, p < 0.01) and reduced \"underscreening\" (101-1000: β = -0.13, p = 0.01; ≥ 1000: β = -0.17, p < 0.01; health insurance association: β = -0.18, p < 0.01; and approaches: β = -0.48, p < 0.01).
CONCLUSIONS: Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in the workplace was suboptimal among Japanese enterprises. Therefore, appropriate cancer screening measures and interventions to ensure guideline adherence and optimization of screening benefits while minimizing potential harms should be expeditiously implemented.
METHODS: A cross-sectional study design was employed. Data were obtained from a survey conducted by the \"Corporate Action to Promote Cancer Control\" between November and December 2022 among registered partner enterprises in Japan. The survey included questions on background characteristics, cancer screening practices, and intervention approaches. The analysis included 432 enterprises that provided complete responses regarding colorectal, breast, and cervical cancer screenings.
RESULTS: The guideline-adherence rates for colorectal, breast, and cervical cancer screenings in the workplace were 12.7%, 3.0%, and 8.8%, respectively. Enterprises had lower adherence to screening guidelines than local governments. Colorectal (70.8%) and breast (67.1%) cancer screenings were predominantly categorized as \"overscreening\" and cervical (60.6%) cancer screening, as \"underscreening.\" Factors such as enterprise scale, health insurance associations, and the number of interventional approaches were significantly associated with increased \"overscreening\" (101-1000: β = 0.13, p = 0.01; ≥ 1000: β = 0.17, p < 0.01; health insurance association: β = 0.23, p < 0.01; and approaches: β = 0.42, p < 0.01) and reduced \"underscreening\" (101-1000: β = -0.13, p = 0.01; ≥ 1000: β = -0.17, p < 0.01; health insurance association: β = -0.18, p < 0.01; and approaches: β = -0.48, p < 0.01).
CONCLUSIONS: Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in the workplace was suboptimal among Japanese enterprises. Therefore, appropriate cancer screening measures and interventions to ensure guideline adherence and optimization of screening benefits while minimizing potential harms should be expeditiously implemented.
摘要：
背景：工作场所癌症筛查计划被确定为员工福利计划的一部分，健康检查被认为是积极的。然而,日本工作场所癌症筛查计划的现状尚不清楚.本研究旨在评估对国家结直肠指南的遵守情况。乳房,在日本企业的工作场所进行宫颈癌筛查，并确定与筛查过度或不充分相关的因素。
方法：采用横断面研究设计。数据来自2022年11月至12月在日本注册合作伙伴企业中进行的“促进癌症控制的企业行动”调查。调查包括关于背景特征的问题，癌症筛查实践，和干预方法。分析包括432家企业，他们提供了关于结直肠的完整回复，乳房,和宫颈癌筛查。
结果：结直肠的指南依从率，乳房,工作场所的宫颈癌筛查率为12.7%，3.0%,和8.8%，分别。与地方政府相比，企业对筛查指南的遵守程度较低。结直肠癌(70.8%)和乳腺癌(67.1%)筛查主要分为“过度筛查”和宫颈癌(60.6%)筛查。作为“低估”。“企业规模等因素，健康保险协会，介入方法的数量与“过度筛查”的增加显着相关（101-1000：β=0.13，p=0.01；≥1000：β=0.17，p<0.01；健康保险协会：β=0.23，p<0.01；方法：β=0.42，p<0.01）和减少的“筛查不足”（101-1000：β=-0.13，p=0.01；≥1000：β-0.01，p=0.18，p=
结论：遵守国家结直肠指南，乳房,在日本企业中，工作场所的宫颈癌筛查效果欠佳。因此,应尽快实施适当的癌症筛查措施和干预措施,以确保指南的依从性和筛查获益的优化,同时将潜在危害降至最低.
方法：采用横断面研究设计。数据来自2022年11月至12月在日本注册合作伙伴企业中进行的“促进癌症控制的企业行动”调查。调查包括关于背景特征的问题，癌症筛查实践，和干预方法。分析包括432家企业，他们提供了关于结直肠的完整回复，乳房,和宫颈癌筛查。
结果：结直肠的指南依从率，乳房,工作场所的宫颈癌筛查率为12.7%，3.0%,和8.8%，分别。与地方政府相比，企业对筛查指南的遵守程度较低。结直肠癌(70.8%)和乳腺癌(67.1%)筛查主要分为“过度筛查”和宫颈癌(60.6%)筛查。作为“低估”。“企业规模等因素，健康保险协会，介入方法的数量与“过度筛查”的增加显着相关（101-1000：β=0.13，p=0.01；≥1000：β=0.17，p<0.01；健康保险协会：β=0.23，p<0.01；方法：β=0.42，p<0.01）和减少的“筛查不足”（101-1000：β=-0.13，p=0.01；≥1000：β-0.01，p=0.18，p=
结论：遵守国家结直肠指南，乳房,在日本企业中，工作场所的宫颈癌筛查效果欠佳。因此,应尽快实施适当的癌症筛查措施和干预措施,以确保指南的依从性和筛查获益的优化,同时将潜在危害降至最低.
